Published online before print March 19, 2007, doi: 10.1161/CIRCULATIONAHA.106.660241
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:1710-1720.)
© 2007 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression
From The Heart Hospital, University College London, United Kingdom.
Correspondence to Prof William J. McKenna, The Heart Hospital, 16–18 Westmoreland St, London W1G 8PH, United Kingdom (E-mail william.mckenna{at}uclh.nhs.uk). Reprint requests to Dr Srijita Sen-Chowdhry, The Heart Hospital, 16–18 Westmoreland St, London W1G 8PH, United Kingdom (E-mail srijita@aol.com, srijita@doctors.org.uk).
Received August 25, 2006; accepted January 12, 2007.
Background— According to clinical-pathological correlation studies, the natural history of arrhythmogenic right ventricular dysplasia/cardiomyopathy is purported to progress from localized to global right ventricular dysfunction, followed by left ventricular (LV) involvement and biventricular pump failure. The inevitable focus on sudden death victims and transplant recipients may, however, have created a skewed perspective of a genetic disease. We hypothesized that unbiased representation of the spectrum of disease expression in arrhythmogenic right ventricular dysplasia/cardiomyopathy would require in vivo assessment of families in a genetically heterogeneous population.
Methods and Results— A cohort of 200 probands and relatives satisfying task force or modified diagnostic criteria for arrhythmogenic right ventricular dysplasia/cardiomyopathy underwent comprehensive clinical evaluation. Desmosomal mutations were identified in 39 individuals from 20 different families. Indices of structural severity correlated with advancing age and were increased in long-term endurance athletes. Fulfillment of modified criteria indicated phenotypically mild disease, whereas asymptomatic status did not. In >80%, ECG, rhythm monitoring, and/or gadolinium-enhanced cardiovascular magnetic resonance were suggestive of LV involvement, the extent of which often was marked among individuals with chain-termination mutations and/or desmoplakin disease. Three patterns of disease expression were identified: (1) classic, with isolated right ventricular disease or LV involvement in association with significant right ventricular impairment; (2) left dominant, with early and prominent LV manifestations and relatively mild right-sided disease; and (3) biventricular, characterized by parallel involvement of both ventricles.
Conclusions— LV involvement in arrhythmogenic right ventricular dysplasia/cardiomyopathy may precede the onset of significant right ventricular dysfunction. Recognition of disease variants with early and/or predominant LV involvement supports adoption of the broader term arrhythmogenic cardiomyopathy.
CLINICAL PERSPECTIVE
This article has been cited by other articles:
 |
|
 |
|
  Y.-J. Wei, C.-J. Cui, Y.-X. Huang, X.-L. Zhang, H. Zhang, and S.-S. Hu Upregulated expression of cardiac ankyrin repeat protein in human failing hearts due to arrhythmogenic right ventricular cardiomyopathy Eur J Heart Fail, June 1, 2009; 11(6): 559 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Hershberger, J. Cowan, A. Morales, and J. D. Siegfried Progress With Genetic Cardiomyopathies: Screening, Counseling, and Testing in Dilated, Hypertrophic, and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Circ Heart Fail, May 1, 2009; 2(3): 253 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sen-Chowdhry, P. Syrris, S. K. Prasad, S. E. Hughes, R. Merrifield, D. Ward, D. J. Pennell, and W. J. McKenna Reply J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1571 - 1572. [Full Text] [PDF]
|
|
|
|
|
|
D. Dalal, H. Tandri, D. P. Judge, N. Amat, R. Macedo, R. Jain, C. Tichnell, A. Daly, C. James, S. D. Russell, et al. Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study. J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1289 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sen-Chowdhry, P. Syrris, S. K. Prasad, S. E. Hughes, R. Merrifield, D. Ward, D. J. Pennell, and W. J. McKenna Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J. Am. Coll. Cardiol., December 16, 2008; 52(25): 2175 - 2187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Braunwald The Management of Heart Failure: The Past, the Present, and the Future Circ Heart Fail, May 1, 2008; 1(1): 58 - 62. [Full Text] [PDF]
|
|
|
|
 |
|
 I. C. Van Gelder, G. Boriani, S. Ernst, H. Heidbuchel, A. Zaza, M. Makijarvi, B. Gorenek, C. B. Lundquist, and on behalf of the EHRA Education Committee Case of the month by the EHRA Education committee: exercise-related arrhythmias Europace, February 1, 2008; 10(2): 256 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.H. W. Tang and G. S. Francis The Year in Heart Failure J. Am. Coll. Cardiol., December 11, 2007; 50(24): 2344 - 2351. [Full Text] [PDF]
|
|
|
|
|
|
S. Sen-Chowdhry, P. Syrris, and W. J. McKenna Role of Genetic Analysis in the Management of Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1813 - 1821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rohr Molecular Crosstalk Between Mechanical and Electrical Junctions at the Intercalated Disc Circ. Res., September 28, 2007; 101(7): 637 - 639. [Full Text] [PDF]
|
|